SCHEMBL13299482

SCHEMBL13299482

C[C@@H](O)/C=C\C(=O)C1=Nc2ccccc2C1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.35
HRH1 P35367 2/20 0.35
TRPA1 O75762 8/20 0.35
NOS3 P29474 1/20 0.33
NOS1 P29475 1/20 0.33
NOS2 P35228 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
HRH4 Q9H3N8 1/20 0.32
RARA P10276 1/20 0.32
RARB P10826 1/20 0.32
RXRA P19793 1/20 0.32
RXRB P28702 1/20 0.32
RXRG P48443 1/20 0.32
LMNA P02545 1/20 0.31
TP53 P04637 1/20 0.31
MAPT P10636 1/20 0.31
HTT P42858 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
PDE3B Q13370 1/20 0.31
PDE3A Q14432 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11989043 0.76 HRH1 (0.38) HTR2AHRH1TRPA1NOS3NOS1
SCHEMBL13356491 0.74 NOS3 (0.41) HTR2AHRH1TRPA1NOS3NOS1
SCHEMBL12083650 0.74 MAPT (0.40) HTR2AHRH1TRPA1NOS3NOS1
SCHEMBL515808 0.72 TRPA1 (0.44) HTR2AHRH1TRPA1NOS3NOS1
SCHEMBL29697828 0.72 TRPA1 (0.44) HTR2AHRH1TRPA1NOS3NOS1
SCHEMBL27008239 0.71 NOS3 (0.50) HTR2AHRH1TRPA1NOS3NOS1
SCHEMBL19690478 0.70 TRPA1 (0.51) TRPA1NOS3NOS1NOS2LMNA
SCHEMBL10176168 0.68 ALDH1A1 (0.45) HTR2AHRH1TRPA1NOS3NOS1
SCHEMBL1574796 0.66 NOS3 (0.37) HTR2AHRH1TRPA1NOS3NOS1
SCHEMBL25761462 0.65 NOS3 (0.33) NOS3NOS1NOS2HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8329905-B2 Synthesis of diethyl{[5-(3-fluorophenyl)-pyridine-2yl]methyl}phosphonate MERCK SHARP & DOHME CORP. (US) 2012-12-11 US disclosed
US-20100137597-A1 SYNTHESIS Of DIETHYLPHOSPHONATE SCHERING CORPORATION 2010-06-03 US disclosed
US-7687631-B2 Synthesis of diethyl{[5-(3-fluorophenyl)-pyridine-2yl]methyl}phosphonate SCHERING CORPORATION (US) 2010-03-30 US disclosed
US-20080004449-A1 Synthesis of diethyl{[5-(3-fluorophenyl)-pyridine-2yl]methyl}phosphonate TOPROL ACQUISITION LLC 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004449-A1 Synthesis of diethyl{[5-(3-fluorophenyl)-pyridine-2yl]methyl}phosphonate F2, F2R, PTAFR HTR2A 310/4885HRH1 219/4885TRPA1 3839/4885
US-20100137597-A1 SYNTHESIS Of DIETHYLPHOSPHONATE F2, PTAFR, TBXA2R HTR2A 426/4885HRH1 167/4885TRPA1 3759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.